| 1 | LLY | Eli Lilly and Company | 18.46% |
| 2 | NVSN.MX | Novartis AG ADR | 10.80% |
| 3 | MRK | Merck & Co., Inc. | 9.95% |
| 4 | PFE | Pfizer Inc. | 5.21% |
| 5 | NVO | Novo Nordisk A/S | 4.88% |
| 6 | SNY | Sanofi | 4.75% |
| 7 | GSK | GSK plc | 4.62% |
| 8 | BMY | Bristol-Myers Squibb Company | 4.62% |
| 9 | JNJ | Johnson & Johnson | 4.41% |
| 10 | MCK | McKesson Corporation | 4.35% |
| 11 | LON: AZN | AstraZeneca PLC | 4.35% |
| 12 | ABBV | AbbVie Inc. | 4.10% |
| 13 | COR | Cencora, Inc. | 3.84% |
| 14 | ZTS | Zoetis Inc. | 3.45% |
| 15 | HLN | Haleon plc | 3.26% |
| 16 | TAK | Takeda Pharmaceutical Company Limited | 3.15% |
| 17 | TEVA | Teva Pharmaceutical Industries Limited | 2.79% |
| 18 | VTRS | Viatris Inc. | 0.90% |
| 19 | JAZZ | Jazz Pharmaceuticals plc | 0.80% |
| 20 | AXSM | Axsome Therapeutics, Inc. | 0.49% |
| 21 | ELAN | Elanco Animal Health Incorporated | 0.35% |
| 22 | CORT | Corcept Therapeutics Incorporated | 0.21% |
| 23 | TSX: BHC | Bausch Health Companies Inc. | 0.10% |
| 24 | OGN | Organon & Co. | 0.10% |
| 25 | PRGO | Perrigo Company plc | 0.06% |
| View PPH holdings |
